BioWin

On November 4th, BioWin and Biovia co-organized a dynamic edition of 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗳𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵, bringing together key actors from the Belgian health and biotech ecosystem. 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲𝗱: 🔹 RLT4BE action plan – Ingrid Maes (Inovigate) presented a national strategy to reinforce Belgium’s life sciences leadership. 🔹 GT4Health initiative – Manon Berger (University of Liège) highlighted the potential of genomics and translational research for precision medicine. 🔹 RegMedXB – a cross-border partnership accelerating regenerative medicine through shared expertise and infrastructure. 🔹 University of Antwerp – promoting translational research and closer ties between academia and industry in advanced therapies. Afternoon breakout sessions explored cutting-edge topics: 🔹 𝗧𝗵𝗲 𝗣𝗿𝗼𝗺𝗶𝘀𝗲 𝗼𝗳 𝗡𝗲𝘄 𝗠𝗼𝗱𝗮𝗹𝗶𝘁𝗶𝗲𝘀: Keeping Belgium in the Lead – moderated by Karine Breckpot, with atbtherapeutics , myNEO Therapeutics, and Railroad Therapeutics. 🔹 𝗔𝗧𝗠𝗣 & 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴: Scaling Innovation in Belgium – moderated by Eva Lion, featuring Abacyra Group, Spectacell, and EXO Biologics . 🎤 The day concluded with a powerful roundtable, “𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝘁𝗼 𝗔𝗻𝗰𝗵𝗼𝗿 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗕𝗲𝗹𝗴𝗶𝘂𝗺”, moderated by Kevin Missault (Deloitte), with contributions from Christian Homsy (Capstan Therapeutics), Ann Van Gysel (Biovia), Xavier Hormaechea (UCB), Amel Tounsi (Noshaq), and Gert Van Assche. The sessions and roundtables clearly demonstrated the added value of working together — across ecosystems, regions, and disciplines — to boost innovation and competitiveness in Belgium and beyond. A big thank you to all speakers, moderators, and participants who made this event a success! Together, we continue to drive innovation and collaboration forward. #BioWin #BIOVIA #ScienceForHealth #LifeSciences #Innovation #Belgium #Ecosystem #Collaboration #ATMP

Insights from #BIOEUROPE2025 - connecting innovation, impact, and policy This week in Vienna, the BioWin team - David Honba and Loïc Germain - joined peers from across Europe to discuss how collaboration can help bring new health innovations to patients faster. 🧬 ATMPs, from lab to patients. In the session “Wallonia Belgium’s ATMP Ecosystem: Innovation in Action,” we explored concrete ways to advance Advanced Therapy Medicinal Products (ATMPs) from research to manufacturing and clinical application: aligning early CMC strategies, adopting data-driven processes, and sharing know-how across companies and institutions. 🌐 Policy that enables, not just regulates. During an international clusters roundtable, discussions on legislation for innovation highlighted a recurring idea: clearer, more predictable frameworks - with early dialogue and digital tools - help smaller innovators navigate complexity and scale faster, ultimately benefiting patients and health systems. We come back from Vienna with new perspectives, valuable learnings, and renewed connections - proud to have represented Wallonia’s vibrant health ecosystem alongside our member companies and partners. Thank you to all who contributed to the meaningful conversations, and to our colleagues at Wallonia Export & Investment Agency (AWEX) - Jean-Philippe Schklar, Terence Zeyer, DANTINNE MARIE ANNE, and Ludovic Waha - for their collaboration throughout the event. Let’s keep turning shared insights into shared impact. #BioWin #Biotech #HealthInnovation #Policy #Collaboration #Vienna #Wallonia #LifeSciences

𝐁𝐢𝐨𝐖𝐢𝐧 𝐚𝐭 𝐁𝐢𝐨𝐄𝐮𝐫𝐨𝐩𝐞 2025 – 𝐋𝐞𝐭’𝐬 𝐂𝐨𝐧𝐧𝐞𝐜𝐭 𝐢𝐧 𝐕𝐢𝐞𝐧𝐧𝐚! BioWin will be attending BioEurope 2025 in Vienna (3-5th November), and we look forward to connecting with partners, innovators, and investors shaping the future of health. You can meet us at the Belgian Pavilion (Hall C, Booth 61), alongside Wallonia Export & Investment Agency (AWEX), where we’ll be representing Wallonia’s dynamic health ecosystem. If you’re attending and would like to explore collaboration opportunities or representation support, don’t hesitate to reach out to Loïc Germain and David Honba — BioWin can help facilitate valuable connections and visibility during the event. We’re also proud to announce that David Honba, BioWin’s COO, will participate in a panel discussion on Advanced Therapy Medicinal Products (ATMPs) alongside Romain de Rauville (Exo Biologics) and Thibault Helleputte (DNAlytics), moderated by Claire Verschelde (ICOSA). The session will spotlight Wallonia’s leadership in ATMP innovation, showcasing how our ecosystem transforms research excellence into industrial and clinical success. 👉 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫𝐬, 𝐩𝐡𝐚𝐫𝐦𝐚𝐬, 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬? Contact the BioWin team to plan a meeting or learn how we can represent you at BioEurope!

Hear insights from Christian Homsy on Belgium’s ATMP landscape, recorded at the latest edition of BioWin Days. He reminds us that Belgium must keep investing in strong ATMP science to turn research excellence into real treatments. Getting proof of concept in patients quickly is essential to create both medical and economic value. Other countries, like Australia, show that smart incentives and pragmatic execution can accelerate innovation. Belgium should do the same. Meet Christian Homsy again at Science for health 2025, where he will deliver the closing keynote, “Building a Biotech Success Story in Belgium.” 4 November 2025 SQUARE Brussels 👉 Register now: https://lnkd.in/eeg_s3Ap Science for Health is organized by BioWin and Biovia , in collaboration with the HST Group (Johnson & Johnson, GSK , UCB , Pfizer )and leading academic and industry partners.

🔥𝟏𝟎𝟎 𝐝𝐚𝐲𝐬 𝐭𝐨 𝐠𝐨 𝐛𝐞𝐟𝐨𝐫𝐞 𝐁𝐞𝐥𝐠𝐢𝐮𝐦’𝐬 𝐛𝐢𝐠𝐠𝐞𝐬𝐭 𝐡𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬 𝐠𝐚𝐭𝐡𝐞𝐫𝐢𝐧𝐠! 🔥 Early bird registrations for the hospitals.be 40th Annual Congress x Health on Stage .be are now open! 👉 Check our website www.healthonstage.be to know more about this unique national matchmaking event.  Secure your early bird ticket now on www.healthonstage.be to make sure you’ll be where hospital decision-makers meet healthtech companies. Powered by: Hospitals.be, BioWin, lifetech.brussels and Biovia #HealthOnStage #HospitalsBE #HealthInnovation #Belgium #HealthcareEcosystem #HealthTech #Collaboration #EarlyBird #national #awards #matchmaking #congress #startups

Vision, innovation and collaboration were the cornerstones of our BioWin 2025 𝐀𝐧𝐧𝐮𝐚𝐥 𝐃𝐢𝐧𝐧𝐞𝐫! Last Thursday, in the magnificent setting of the Palais d’Afrique in Tervuren, we had the pleasure of welcoming more than 120 𝐂-𝐥𝐞𝐯𝐞𝐥 𝐥𝐞𝐚𝐝𝐞𝐫𝐬 𝐟𝐫𝐨𝐦 𝐖𝐚𝐥𝐥𝐨𝐧𝐢𝐚’𝐬 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦. Thank you all for your presence, energy and insightful exchanges! A special thank you to our inspiring speakers for their valuable contributions:  • Jean-Luc Morelle, CEO of Trasis  • Rebecca Lo bue & Efrain Perini, Oncidium Foundation As announced in a previous post, the evening was highlighted by a major milestone:  👉 𝐁𝐢𝐨𝐖𝐢𝐧 𝐢𝐬 𝐩𝐚𝐫𝐭𝐧𝐞𝐫𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 Oncidium foundation, an independent non-profit organisation dedicated to improving global access to 𝐫𝐚𝐝𝐢𝐨𝐭𝐡𝐞𝐫𝐚𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐜𝐚𝐧𝐜𝐞𝐫 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭. This members-only event offered a unique opportunity to engage in high-level discussions on key challenges and opportunities shaping the biopharma and health-tech sectors. Thanks to our Sponsor: Akkodis, Deloitte, GSK, Kadans Science Partner, PwC, Thermo Fisher Scientific Onward together—towards impact and innovation!

💥 A world first in Belgium! Patients can now take the lead in clinical research thanks to The Patient Voice Database, a groundbreaking platform co-created by the Patient Expert Center and Curewiki. This digital bridge connects patients directly with clinical research, making participation simple, secure and empowering. “We’ve turned the paradigm around. Researchers no longer have to look for patients, patients now find their way to research,” says Stefan Gijssels, Chair of the Patient Expert Center. “Already, more than 16,000 Belgians are registered on the platform, which is free, secure, and fully GDPR-compliant,” adds Jean-Sébastien Gosuin, founder of Curewiki. “Our ambition is to keep growing this ecosystem together with hospitals and patient organisations, and to extend it across Europe.” 👉 Read the full release: https://lnkd.in/eGHsfbf3

BioWin is joining forces with the Oncidium foundation, an independent non-profit organisation dedicated to ensuring equal access to radioligand therapy for cancer care. Officially announced yesterday during our Annual Dinner, this partnership builds on a shared vision: to boost collaboration and innovation in nuclear medicine and radiopharmaceuticals, in Belgium and beyond. Together, BioWin and Oncidium will focus on expanding access to life-saving radioisotopes, raising awareness around their potential, and working hand in hand with public authorities, hospitals and research centres. A joint steering committee, led by David Honba (BioWin) and Efrain Perini (Oncidium Foundation), will guide and follow up on the work ahead. Sylvie Ponchaut, CEO of BioWin, said: “We are thrilled to partner with the Oncidium Foundation. Together, we will leverage Wallonia’s scientific excellence and Oncidium’s international reach to promote Belgium as a leading center for radiopharmaceutical innovation.” 👉 See the full release: https://lnkd.in/eh_XDfFA

Belgium invests heavily in research and innovation, as seen in the numerous spinouts and startups with brilliant potential. But as they grow, many reach a point where local support isn’t enough. They look beyond Europe for manufacturing, clinical trials, and funding. So how can Belgium close this gap and help our companies stay and scale here at home? At Science for health 2025 on 4 November in Brussels, Jerome Van Biervliet (VIB/Biovia) will tackle this challenge in his keynote: “Rooted for Impact: Keeping Innovation and Investment in Belgium.” He explains that the key lies in bigger venture funds, regulatory alignment, local manufacturing, and faster, data-driven clinical trials, because: "Together, we can show Europe how it can be done." Join us to see how Belgium is shaping the future of advanced therapies by turning collaboration into impact. Date: 4 November 2025 Location: SQUARE Brussels 👉 Register now: https://lnkd.in/eeg_s3Ap

🌎 Biowin at the Belgian Economic Mission to California 2025 🇧🇪🇺🇸 A truly inspiring week in California for BioWin, strengthening transatlantic ties in life sciences and innovation. Huge thanks to Wallonia Export & Investment Agency (AWEX), Pascale Delcomminette, Hubert Goffinet, and their entire team - as well as all partners - for an outstanding program connecting Belgium and California’s vibrant ecosystems. 🎤 David Honba, COO of Biowin, moderated the plenary panel “Belgium & California Life Sciences Ecosystems: A Dialogue” at Genentech in San Francisco - exploring how both regions cultivate talent, drive innovation, and foster collaboration across borders. A warm thank-you to our exceptional panelists: ⭐ Dieter Deforce (University Ghent) ⭐ Dominique Demonte (BioPark Charleroi) ⭐ Tim Scott (Biocom California) ⭐ Jeremy Alberga (Bakar Bio Labs, University of California, Berkeley) 💡 Sylvie Ponchaut, CEO of Biowin, joined the fireside chat “Building Bridges in Biomanufacturing: Ecosystem Perspectives from Wallonia and Los Angeles” at BioscienceLA, alongside Stephanie Hsieh (Executive Director, BioscienceLA). The discussion highlighted how Wallonia and California can learn from one another to strengthen biomanufacturing capacity and develop the next generation of skilled professionals - underlining shared best practices and new avenues for long-term collaboration and growth. We return to Belgium energized and determined to turn these connections into impactful partnerships for global health innovation. #BEmissionUSA #BelgiumMeetsCalifornia #LifeSciences #Biotech #Innovation #TransatlanticCollaboration #Wallonia